Aspira Women's Health Inc.
AWHL- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000926617
No open-market purchases or sales by Aspira Women's Health Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Aspira Women's Health Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- −1 vs. Q4 2024
- Shares held
- 864.2K
- −592.9K (−40.7%) vs. Q4 2024
- Total value
- $81.0K
- −$946.5K (−92.1%) vs. Q4 2024
- New holders
- 3
- 9 more added
- Sold out
- 4
- 5 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AWHL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $392 |
| Q2 2025 | 2 | $15.7K |
| Q1 2025 | 25 | $81.0K |
| Q4 2024 | 26 | $1.03M |
| Q3 2024 | 25 | $1.91M |
| Q2 2024 | 26 | $2.08M |
| Q1 2024 | 23 | $6.15M |
| Q4 2023 | 24 | $2.92M |
| Q3 2023 | 24 | $3.53M |
| Q2 2023 | 22 | $1.75M |
| Q1 2023 | 45 | $3.25M |
| Q4 2022 | 47 | $3.24M |
| Q3 2022 | 58 | $4.46M |
| Q2 2022 | 72 | $7.02M |
| Q1 2022 | 92 | $22.9M |
| Q4 2021 | 98 | $50.9M |
| Q3 2021 | 92 | $97.0M |
| Q2 2021 | 95 | $174.1M |
| Q1 2021 | 97 | $211.5M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Aspira Women's Health Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HRT Financial LP | 182,286 | $17.0K | 0.00% | +182,286 | New |
| Geode Capital Management, LLC | 131,968 | $12.4K | 0.00% | +33,860+34.5% | Added |
| BlackRock, Inc. | 82,232 | $7.72K | 0.00% | −535−0.6% | Reduced |
| Vanguard Group Inc | 79,183 | $7.44K | 0.00% | −194,906−71.1% | Reduced |
| Bank of America Corp | 63,528 | $5.91K | 0.00% | +5,221+9.0% | Added |
| XTX Topco Ltd | 62,184 | $5.84K | 0.00% | +62,184 | New |
| Virtu Financial LLC | 52,851 | $5.00K | 0.00% | +40,543+329.4% | Added |
| UBS Group AG | 34,196 | $3.21K | 0.00% | +32,151+1,572.2% | Added |
| Pine Valley Investments Ltd Liability Co | 33,400 | $3.14K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 29,808 | $2.80K | 0.00% | +8,279+38.5% | Added |
| The PNC Financial Services Group, Inc. | 25,000 | $2.35K | 0.00% | +10,000+66.7% | Added |
| Northeast Financial Consultants Inc | 23,436 | $2.20K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 19,749 | $1.85K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 16,799 | $1.58K | 0.00% | −11,981−41.6% | Reduced |
| M&T Bank Corp | 14,999 | $1.41K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,130 | $388 | 0.00% | −30−0.7% | Reduced |
| Advisor Group Holdings, Inc. | 2,650 | $240 | 0.00% | +1,151+76.8% | Added |
| JPMorgan Chase & Co | 2,061 | $194 | 0.00% | −3−0.1% | Reduced |
| Morgan Stanley | 1,694 | $159 | 0.00% | +78+4.8% | Added |
| Operose Advisors LLC | 1,000 | $94 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 610 | $57 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 199 | $19 | 0.00% | +178+847.6% | Added |
| Group One Trading, L.P. | 119 | $11 | 0.00% | 00.0% | Unchanged |
| Danske Bank A/S | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 100 | $0 | 0.00% | +100 | New |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −710,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −29,616−100.0% | Sold out |
| Quantum Private Wealth, LLC | 0 | $0 | 0.00% | −21,799−100.0% | Sold out |
| Global Wealth Strategies & Associates | 0 | $0 | 0.00% | −18−100.0% | Sold out |